ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,827Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 298

$722K Total Retail Price of All Prescriptions

Rank: 5 out of 298

300 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 300 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 300 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,307 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
CRESTOR 558 511 1 26
LEVOTHYROXINE SODIUM 370 351 2 1
OMEPRAZOLE 277 258 3 3
AMLODIPINE BESYLATE 258 258 4 6
SIMVASTATIN 250 238 5 2
HYDROCHLOROTHIAZIDE 181 179 6 13
TRILIPIX 173 161 7 172
BYSTOLIC 172 169 8 127
POTASSIUM CHLORIDE 138 132 9 11
ALLOPURINOL 132 110 10 28
TORSEMIDE 130 114 11 110
JANUVIA 125 125 12 73
AVODART 123 106 13 115
METOPROLOL SUCCINATE 121 121 14 12
SPIRIVA 120 116 15 55
WARFARIN SODIUM 116 116 16 7
TAMSULOSIN HCL 110 97 17 24
ATORVASTATIN CALCIUM 109 103 18 14
METFORMIN HCL ER 108 105 19 57
DIGOXIN 105 105 20 27
TRICOR 93 93 21 176
CARVEDILOL 89 85 22 23
CELEBREX 89 89 22 86
DIOVAN 85 80 24 47
TEKTURNA 82 65 25 179
AMLODIPINE BESYLATE-BENAZEPRIL 82 76 25 98
LOSARTAN POTASSIUM 81 81 27 18
ATENOLOL 81 76 27 16
FENOFIBRATE 78 78 29 62
METOPROLOL TARTRATE 77 65 30 9
DIOVAN HCT 77 77 30 130
FUROSEMIDE 77 75 30 5
MICARDIS HCT 75 75 33 206
NEXIUM 70 66 34 40
ATACAND HCT 68 68 10 35 213
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 57 35 30
MICARDIS 63 61 37 216
ULORIC 61 61 38 219
ACETAMINOPHEN-CODEINE 59 59 S3 39 119
TRAMADOL HCL 58 52 40 15
DONEPEZIL HCL 57 57 41 22
GABAPENTIN 55 55 42 20
ALENDRONATE SODIUM 54 54 43 21
ZOLPIDEM TARTRATE 54 42 43 25
FINASTERIDE 52 52 45 66
LOSARTAN-HYDROCHLOROTHIAZIDE 52 52 45 44
FLUTICASONE PROPIONATE 52 51 45 38
HYDROCODONE-ACETAMINOPHEN 51 43 S3 48 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.